FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to medical diagnostics, and describes a method for prediction of a survival rate in the patients suffering liver metastases of colorectal cancer after a partial hepatectomy. The method involves studying tumour biopsy material of the liver after the partial hepatectomy by immune histochemical test and analysing the tumour microenvironment characteristics, including a stroma area, a lymphocytic infiltration area (if any), a quantity of vessels (if any) with smooth muscle actin in the vascular wall in the tumour stroma of a liver metastasis in three fields of microscope; the fields are specified according to highest-grade possible immune histochemical test, and if observing the stroma area of 50% and more of total visual field area, the lymphocytic infiltration area of 50% and more of the stroma area accompanied by the vessels with adequately developed smooth muscles in the vascular wall in at least two fields, the patient is grouped as having a favourable prognosis of the overall survival, while the stroma area of less than 25% of the total visual field area, the absence of the lymphocytic infiltration or its area of less than 10% of the stroma area and the absence of the vessels with smooth muscle actin in the tumour stroma of the liver metastasis in at least fields, the patient is predicted to have an unfavourable prognosis.
EFFECT: method provides the more accurate prediction of the overall survival after the partial hepatectomy for metastatic colorectal cancer and can be used in surgery and oncology.
7 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF OVERALL SURVIVAL IN PATIENTS SUFFERING FROM LIVER METASTASES OF COLORECTAL CANCER FOLLOWING HEPATIC RESECTION | 2013 |
|
RU2530608C1 |
METHOD FOR PREDICTION OF OVERALL SURVIVAL IN PATIENTS SUFFERING FROM LIVER METASTASES OF COLORECTAL CANCER FOLLOWING HEPATIC RESECTION | 2013 |
|
RU2530610C1 |
METHOD OF PREDICTING RELAPSE-FREE SURVIVAL OF PATIENTS WITH COLORECTAL CANCER METASTASES IN LIVER AFTER ITS RESECTION | 2011 |
|
RU2454176C1 |
METHOD OF PREDICTING RELAPSE-FREE SURVIVAL BY CLINICAL AND PATHOLOGIVCAL FACTORS IN PATIENTS WITH METASTASES OF COLORECTAL CANCER IN LIVER AND AFTER ITS RESECTION | 2011 |
|
RU2452373C1 |
METHOD OF TREATING LOCALLY ADVANCED STOMACH CANCER WITH HIGH METABOLIC AND PROLIFERATIVE ACTIVITY | 2014 |
|
RU2552289C1 |
METHOD FOR PREDICTING RELAPSE FREE SURVIVAL IN PATIENTS WITH COLORECTAL CANCER LIVER METASTASES AFTER LIVER RESECTION USING MOLECULAR FACTORS | 2011 |
|
RU2442983C1 |
METHOD FOR TREATING METASTASES OF COLORECTAL CANCER IN THE LIVER | 2017 |
|
RU2663800C2 |
METHOD FOR PREDICTION OF LIFE EXPECTANCY IN PATIENTS WITH METASTATIC TUMORS | 2023 |
|
RU2821659C1 |
METHOD FOR PREDICTION OF RISK OF RECURRENT DISEASE OF SQUAMOUS CELL LUNG CANCER OF STAGE IIB-IIIA IN PATIENTS RECEIVING ADJUVANT POLYCHEMOTHERAPY AFTER RADICAL SURGERY | 2023 |
|
RU2815575C1 |
METHOD FOR PREDICTING THE DURATION OF A RELAPSE-FREE PERIOD IN PATIENTS WITH RESECTABLE THRICE-NEGATIVE BREAST CANCER | 2021 |
|
RU2780922C1 |
Authors
Dates
2015-11-20—Published
2013-05-27—Filed